AK
Arthur Kuan bought $2.4M of CGON stock
Arthur Kuan, Chief Executive Officer of CG Oncology, Inc. (CGON), bought 30,000 shares of CGON stock worth $2.4M, per an SEC Form 4 filed Nov 18, 2026.
It was an open-market purchase.
The trade was reported on Nov 18, 2026.
CGON has moved -0.7% since the trade date, from $80.00 to $79.47 (Nov 20, 2026 close).
- Traded
- Nov 18, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 0 days
- Price since
- -0.7%
- Role
- Chief Executive Officer
- Source
- SEC Form 4